Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Greg
    Member
    • Oct 2009
    • 31

    Cuffdiff NOTEST for splicing.diff

    Using the tophat/cufflinks combo to find differential alternative splicing.

    The cuffdiff manual says that if there "not enough alignments for testing" then you will get NOTEST and the treatments will not be compared. Does anyone have an idea as to what the cutoff for this is? Many of the genes that get NOTEST in my data set (single end) have a large number of reads (several hundred). Could it be because of insufficient coverage? or maybe operator error?

    thanks!
  • Greg
    Member
    • Oct 2009
    • 31

    #2
    So I just found the -c option to set the number of required reads. It does change the number of tests that happen but there are still less then I would think. Any ideas? What are the other criteria for doing the test or not? Would more info on my workflow be helpful?

    Comment

    • griffon42
      Member
      • Jan 2009
      • 23

      #3
      I'm experiencing the same issue. I'm using cufflinks 0.8.3 (the 7/2 release) and the -c option doesn't seem to work as described in the manual. As extreme examples, I have loci that are "OK" for stat testing and "yes" for significant but have only 2 reads vs. 0 reads across samples.

      As mentioned, changing -c DOES affect the number of loci tested, but not by much and it does not fix situations like that described above.

      Does anyone know how to manage this situation? The differential expression output files i'm generating are rather unmanageable.

      Thanks.

      Comment

      • jetspeeder
        Member
        • Jun 2010
        • 12

        #4
        I have a lot of NOTEST and FAIL as well,

        Also do you guys know the significance of this and why the percentages are high for missed and wrong exons and what the signifies? Thanks.

        #> Genomic sequence: chr1
        # Query mRNAs : 20972 in 20055 loci (3356 multi-exon transcripts)
        # (633 multi-transcript loci, ~1.0 transcripts per locus)
        # Reference mRNAs : 1024 in 912 loci (966 multi-exon)
        # Corresponding super-loci: 695
        #--------------------| Sn | Sp | fSn | fSp
        Base level: 63.4 16.4 - -
        Exon level: 37.6 9.6 44.0 11.3
        Intron level: 52.6 31.5 53.4 31.9
        Intron chain level: 18.6 5.4 24.7 7.1
        Transcript level: 0.0 0.0 0.1 0.0
        Locus level: 19.5 0.9 22.9 1.0
        Missed exons: 2554/8302 ( 30.8%)
        Wrong exons: 26036/32327 ( 80.5%)
        Missed introns: 3161/7289 ( 43.4%)
        Wrong introns: 7825/12186 ( 64.2%)
        Missed loci: 208/912 ( 22.8%)
        Wrong loci: 17823/20055 ( 88.9%)

        Comment

        • Greg
          Member
          • Oct 2009
          • 31

          #5
          I've had the same experience. Could only guess...

          Comment

          • SEQond
            Member
            • Jul 2010
            • 27

            #6
            So anyone has an idea on how to find the ideal -c "minimum number of alignments in a locus for needed to conduct significance testing" (--min-alignment-count) ?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Nine Things a Sample Prep Scientist Thinks About Before Sequencing
              by SEQadmin2


              I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


              Here are nine questions we think about, in roughly the order they matter, before...
              Today, 07:11 AM
            • SEQadmin2
              From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
              by SEQadmin2


              Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


              The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
              ...
              06-02-2026, 10:05 AM
            • SEQadmin2
              Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
              by SEQadmin2


              With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


              Introduction

              Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
              05-22-2026, 06:42 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 06:09 AM
            0 responses
            16 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-09-2026, 11:58 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-05-2026, 10:09 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 06-04-2026, 08:59 AM
            0 responses
            49 views
            0 reactions
            Last Post SEQadmin2  
            Working...